Mycobacterium tuberculosis
Mycobacterium tuberculosis is the bacterial pathogen responsible for tuberculosis (TB), a major global infectious disease that primarily affects the lungs but can also disseminate to other organs.
Mycobacterium tuberculosis is the bacterial pathogen responsible for tuberculosis (TB), a major global infectious disease that primarily affects the lungs but can also disseminate to other organs. It is an intracellular, slow-growing mycobacterium with a distinctive cell envelope and a strong capacity to persist within host macrophages, which contributes to chronic infection, immune evasion, and prolonged treatment requirements. In biomedical research, M. tuberculosis is commonly abbreviated as Mtb or MTB.
The organism is a central target in anti-tubercular drug discovery, vaccine development, host-directed therapy, and diagnostic research. Its biology is studied through virulence factors, metabolic pathways, and strain-specific differences, including drug-sensitive and drug-resistant isolates. Recent work has also focused on antigenic targets such as Ag85B and PstS1, essential enzymes and pathways such as InhA and biotin biosynthesis, and host-pathogen interactions involving macrophage survival, ferroptosis, and inflammatory signaling.
Where the papers sit
12 papers from the last 6 months study mycobacterium tuberculosis directly · updated from PubMed 11 Nov 2026
Study type 0 clinical trials · 1 observational · 2 human data · 9 preclinical
Themes 3 themes
-
Antitubercular Drug Discovery
Antitubercular discovery is broadening beyond established scaffolds through medicinal chemistry and resistance-guided screening. Heterocycles, quinolones, cephalosporin prodrugs and diphenylterephthalamides are being evaluated for activity against Mycobacterium tuberculosis. Several candidates deliberately combine antimycobacterial and anti-inflammatory or carbonic anhydrase-inhibitory effects. In silico prioritization, in vitro testing and ClpP-targeted natural-product discovery remain early-stage routes toward new agents.
6 papers · 50%
-
Tuberculosis Diagnostic Detection
Tuberculosis diagnosis is moving toward rapid, targeted detection across diverse clinical samples. Amplification-free CRISPR-Cas12a electrochemiluminescence biosensors complement multiplex PCR for suspected tuberculous meningitis. Deep-learning analysis of Ziehl-Neelsen sputum images aims to automate bacillary detection and improve precision. The shared goal is faster, more accessible identification than conventional microscopy alone.
3 papers · 25%
-
Tuberculosis Persistence and Immunity
Tuberculosis persistence is being linked to pathogen evolution and protected cellular niches during immune restoration. Intrahost genome sequencing tracks distinct Mycobacterium tuberculosis mutational trajectories in simian immunodeficiency virus infection and after antiretroviral therapy. Monocytic niches in lymph nodes can evade T-cell surveillance, supporting persistence and dissemination. The work points toward combining immune-recovery studies with bacterial evolution and tissue-level analyses.
3 papers · 25%
Papers
The 12 papers from the last 6 months that study mycobacterium tuberculosis directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Antitubercular Drug Discovery (6)
- Screening of diphenylterephthalamide derivatives against Mycobacterium tuberculosis: an in silico and in vitro study. Bioorganic chemistry · 1 Sept 2026 PMID 42679741
- Oxadiazole and hydrazone derivatives of benzimidazothiazine as potential antifungal and anti-tubercular agents. Bioorganic chemistry · 24 Jul 2026 PMID 42497767
- Resistance-CONKAT-seq Guided Discovery of a ClpP Active Natural Product from a Soil Metagenome. ACS chemical biology · 29 Jun 2026 PMID 42366525
- First-in-class nonsteroidal anti-inflammatory drug and carbonic anhydrase inhibitor hybrid compounds as effective antimycobacterial agents. European journal of medicinal chemistry · 12 Jun 2026 PMID 42284634
- Synthesis of 4-Aminoindole-Containing Cephalosporin Prodrugs and Their Biological Activity against Mycobacterium tuberculosis. ACS infectious diseases · 9 Jun 2026 PMID 42262488
- Guanilated Quinolones with Dual Antitubercular and Anti-Inflammatory Activities. ChemMedChem · 27 May 2026 PMID 42202039
Tuberculosis Diagnostic Detection (3)
- A novel Ziehl-Neelsen sputum smear image database and deep learning strategy for automated detection of tuberculosis bacilli. Computers in biology and medicine · 23 Sept 2026 PMID 42777592
- Amplification-free electrochemiluminescence biosensors based on peptide-templated gold nanocluster and CRISPR-Cas12a for Mycobacterium tuberculosis IS6110 detection. Analytica chimica acta · 19 Sept 2026 PMID 42763149
- Etiologic diagnosis of suspected tuberculous meningitis by multiplex PCR of cerebrospinal fluid. Journal of clinical microbiology · 20 Aug 2026 PMID 42623488
Tuberculosis Persistence and Immunity (3)
- Reading immune restoration through Mycobacterium tuberculosis intrahost evolution. mSystems · 22 Sept 2026 PMID 42770717
- Population-level genome sequencing reveals distinct Mycobacterium tuberculosis intrahost mutational trajectories in simian immunodeficiency virus-coinfected and antiretroviral treated non-human primates. mSystems · 27 Jul 2026 PMID 42505123
- Monocytic niches escape T cell surveillance and promote Mycobacterium tuberculosis persistence in lymph nodes. Immunity · 23 Jun 2026 PMID 42335893
By study type
Observational studies and case reports (1)
- Etiologic diagnosis of suspected tuberculous meningitis by multiplex PCR of cerebrospinal fluid. Journal of clinical microbiology · 20 Aug 2026 PMID 42623488
Human data, design not indexed (2)
- A novel Ziehl-Neelsen sputum smear image database and deep learning strategy for automated detection of tuberculosis bacilli. Computers in biology and medicine · 23 Sept 2026 PMID 42777592
- Amplification-free electrochemiluminescence biosensors based on peptide-templated gold nanocluster and CRISPR-Cas12a for Mycobacterium tuberculosis IS6110 detection. Analytica chimica acta · 19 Sept 2026 PMID 42763149
Preclinical: animal, cell and lab studies (9)
- Reading immune restoration through Mycobacterium tuberculosis intrahost evolution. mSystems · 22 Sept 2026 PMID 42770717
- Screening of diphenylterephthalamide derivatives against Mycobacterium tuberculosis: an in silico and in vitro study. Bioorganic chemistry · 1 Sept 2026 PMID 42679741
- Population-level genome sequencing reveals distinct Mycobacterium tuberculosis intrahost mutational trajectories in simian immunodeficiency virus-coinfected and antiretroviral treated non-human primates. mSystems · 27 Jul 2026 PMID 42505123
- Oxadiazole and hydrazone derivatives of benzimidazothiazine as potential antifungal and anti-tubercular agents. Bioorganic chemistry · 24 Jul 2026 PMID 42497767
- Resistance-CONKAT-seq Guided Discovery of a ClpP Active Natural Product from a Soil Metagenome. ACS chemical biology · 29 Jun 2026 PMID 42366525
- Monocytic niches escape T cell surveillance and promote Mycobacterium tuberculosis persistence in lymph nodes. Immunity · 23 Jun 2026 PMID 42335893
- First-in-class nonsteroidal anti-inflammatory drug and carbonic anhydrase inhibitor hybrid compounds as effective antimycobacterial agents. European journal of medicinal chemistry · 12 Jun 2026 PMID 42284634
- Synthesis of 4-Aminoindole-Containing Cephalosporin Prodrugs and Their Biological Activity against Mycobacterium tuberculosis. ACS infectious diseases · 9 Jun 2026 PMID 42262488
- Guanilated Quinolones with Dual Antitubercular and Anti-Inflammatory Activities. ChemMedChem · 27 May 2026 PMID 42202039
Written from 12 PubMed abstracts, each one listed by PMID above. Published: 2026-07-01. Last written: 2026-08-26 by GPT. Drafted by language models from published abstracts; not medical advice.